Background. Micronutrient deficiencies may contribute to a higher incidence of low birthweight (LBW). UNICEF/United Nations University/World Health Organization jointly proposed a formulation for a multiple micronutrient supplement for pregnant women, and several effectiveness trials were conducted to assess its impact.
Background
Low birthweight (LBW) is associated with many adverse effects. LBW increases the risk of perinatal mortality by more than 10-fold and is associated with four times the risk of postneonatal mortality [1, 2] . LBW is linked with decreased intelligence, poor school performance, decreased ability to compete in the workplace, and increased poverty [3] [4] [5] . When they reach adulthood, LBW babies are more likely to suffer from degenerative diseases, including hypertension, diabetes, and atherosclerosis [6] [7] [8] [9] [10] .
Dietary intake and micronutrient status studies show that maternal micronutrient deficiencies in iron, vitamin A, zinc, vitamin B 12 , iodine, and folate are widespread and have a negative impact on pregnancy outcomes. Current data suggest a plausible role for iron, zinc, and vitamin A in improving birth outcomes, including birthweight [11] [12] [13] .
Although it is common for women in industrialized countries to take multivitamin supplements during pregnancy, until recently a multiple micronutrient supplement specifically designed for use by women in developing countries has not existed. In 1999, UNICEF,
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Preventing low birthweight the World Health Organization (WHO), and the United Nations University (UNU) jointly proposed a composition of a multiple micronutrient supplement for pregnant women in developing countries to be used in efficacy and effectiveness trials to assess its impact-the United Nations International Multiple Micronutrient Preparation (UNIMMAP). The contents of the supplement are shown in the Huy et al. article in this journal supplement [14] . A number of issues related to maternal micronutrient supplementation needing further investigation were identified. UNICEF/UNU/WHO recommended further study of indicators related to birth outcome, including assessment of anthropometry at birth. It was also recommended that pregnancy outcome as well as biochemical markers of the nutritional status of the mother be investigated [12] .
In order to evaluate the effect of the UNICEF/UNU/ WHO proposed supplement on these outcomes, this study was carried out from May 2001 through September 2003 in Indramayu, Indonesia.
Objective
The objective was to evaluate the effect of supplementation with the recommended multiple micronutrient supplement in comparison with iron-folic acid on birth size, pregnancy outcome, and micronutrient status in women.
Methods

Study population
Two subdistricts of Indramayu District in the West Java Province of Indonesia were chosen to represent an average district in terms of economic development and health status. Previous studies indicated a high prevalence of anemia among pregnant women in this study area [15, 16] . These two subdistricts have populations of 67,082 and 52,135, include 25 villages, and are divided into 157 hamlets.
The sample size was calculated based on 80% study power to be able to detect a 50% reduction in the incidence of LBW among the treated group as compared with the control group and allow a type I error at α = .05 for a one-sided test. We used 0.1 as the estimated proportion of LBW among the control group in the sample calculation [15] . The sample was then increased to allow for dropout due to rejection or migration and adjustment for the design effect due to randomization according to dwelling block. The total sample required was 428 for each group [17] .
Registration of pregnant women took place from May 2001 through December 2002. The last woman in the sample gave birth in August 2003. Pregnancy status was confirmed with a dipstick pregnancy test (Acon Laboratories), and then the woman was asked to recall the first day of her last menstrual period. Only those intending to remain in the study location until giving birth were recruited. Women suffering from potentially confounding illnesses, including diabetes, coronary heart disease, and tuberculosis, were excluded from the study. All women were required to provide written informed consent in order to participate. Ethical clearance for the study protocol was obtained from the Ethical Committee of the University of Indonesia, Depok.
Study design
The design of the study was a randomized community trial in which a cluster of dwellings served as the unit for randomization. We restructured the 157 hamlets into 160 dwelling clusters to obtain an equal number of households in every cluster and clear physical boundaries between clusters. These 160 clusters (and the pregnant women living within them) were randomly assigned to 4 blocks of 40 clusters each. Two of the four blocks were part of an effectiveness trial (not reported in this paper), and women in the other two blocks received either the multiple micronutrient supplement or iron-folic acid.
The fieldworkers carried out intensive surveillance to identify all pregnant women in the clusters, checking mothers at religious gatherings and posyandu (growth promotion and monitoring posts) or directly contacting the traditional birth attendants in order to identify any new pregnant women. There were 843 eligible women who were located this way and enrolled in this study; 432 women in 40 clusters were allocated to the group receiving multiple micronutrients and 411 in the other 40 clusters were allocated to the iron-folic acid group.
This study had a single-blind design, since the supplements for the treatment and control groups looked different physically. However, participants residing in each cluster received the same supplement, so they were not aware that participants in other clusters received a different supplement. Supplements were given from the time of enrollment at 12 to 20 weeks of gestation and continued up to 30 days postpartum.
The multiple micronutrient supplements contained the recommended daily allowance of 15 micronutrients according to the UNICEF/UNU/WHO recommended formula, including 30 mg of ferrous fumarate. They were supplied by UNICEF Jakarta and were produced by PT SOHO Pharmaceutical Company, Jakarta, to ensure that the supplement met Muslim hallal standards [12] . The iron-folic acid supplements contained 60 mg of elemental iron as ferrous sulfate and 0.25 mg of folic acid and were purchased from PT Kimia Farma, Jakarta. To ensure that the participants received the full recommended dosage of the supplement, the women in the intervention and control groups were visited daily (except Sunday) and the supplement was dispensed to them by the fieldworkers, with consumption of the supplements observed. The consumption of vitamins and minerals dispensed from other sources was assessed by daily direct monitoring. Local health centers were advised not to dispense redundant iron-folic acid tablets to those women already receiving supplements from the study. Women were advised to discontinue the use of vitamins and minerals from other sources, and any additional use was recorded. If the woman did not discontinue use of additional supplements, she was excluded from the analysis. The fieldworkers also encouraged all study participants to receive antenatal care checks at their local health centers and recorded their antenatal care visits.
Measurement of outcomes
Under the guidance of local health service staff, the fieldworkers established a communication network with local traditional birth attendants in order to identify any woman giving birth and to immediately measure the newborn. Birthweight was measured by a spring-type infant scale (Misaki, Japan) to the nearest 50 g. Birth length was measured with a WHO standard length board [18] to the nearest 1 mm. Head and chest circumferences were measured with a fiberglass measuring tape (Butterfly, Japan) to the nearest 1 mm. All measurements were taken twice. If different results were obtained, a third measurement was taken and the average value was recorded. The measurement tools were strictly calibrated every morning. We used standard weight and standard length instruments produced by the Metrology Office for routine calibration of scales and length measurements.
Venous blood specimens and urine samples were taken randomly from 25% of the subject women at the beginning of the study and repeated again at approximately 8 months of gestation by phlebotomists from the National Nutrition Research Institute in Bogor. The blood specimens were analyzed for hemoglobin, serum ferritin, serum zinc, and serum retinol; the urine was analyzed for iodine concentration. Analyses were performed in the certified laboratory of the Bogor Nutrition Research Institute. The hemoglobin concentration in the peripheral blood was measured directly with a hemoglobin reader (HemoCue) in all women at baseline and at 8 months of gestation.
Data on compliance and side effects of supplementation as well as morbidity and fetal loss were collected from weekly visits. Miscarriage or spontaneous abortion was defined as termination of pregnancy before 28 weeks; stillbirth was defined as fetal loss from 28 weeks or later up to birth, but without sign of life. We defined neonatal death as death of a live-born infant up to 28 days after birth. There was no in-depth effort to identify the cause of death by verbal autopsy. Reports on fetal loss and neonatal death were double-checked directly with the mothers by the field coordinators.
Analytical methods
We excluded all twins from the analysis of birthweight and pregnancy outcome. Infants whose birth size was measured later than 3 days after birth were excluded from the analyses of birthweight. We also excluded any outcomes of pregnancy among women who migrated to other districts.
Characteristics of the subjects at baseline were compared between the intervention and control groups to check whether randomization was successful. Pregnancy outcomes and confounding factors were compared across treatment groups in terms of mean differences for numeric variables or odds ratios for categorical variables. Rates of miscarriage, stillbirth, and neonatal death were compared between groups. Because of the small number of events, these categories were then combined into one pregnancy outcome category for analysis. The impact of supplementation on pregnancy outcome was also analyzed for the subgroups of women consuming fewer than 90 supplements compared with those consuming 90 or more supplements.
Results
Recruitment was stopped after recruitment of 1,737 pregnant woman, which was enough to yield the calculated sample size. Of these 1,737 women, 43 declined to participate and 1,694 agreed to take part in the two multiple micronutrient studies. There were 843 pregnant women in this study, while the remaining 851 pregnant women participated in a parallel effectiveness study in which women were given a month's supply of supplements rather than being given them daily. Of the 843 women in this trial, 51 migrated or dropped out of the study because of illness or refusal to participate, and 37 pregnancies resulted in miscarriage or stillbirth ( fig. 1) .
A total of 393 women in the group receiving multiple micronutrients and 357 in the group receiving iron-folic acid (89% of initial participants) delivered a live-born infant who was measured by the fieldworkers. Five of these women delivered twins and were thus excluded from the analysis. Forty-four percent of infants were measured on the day of birth, 93% within 2 days after birth, and 97% within 3 days after birth.
There were no major differences between the two groups in baseline demographic characteristics (table 1). On average, the women were 25 or 26 years of age, and 43% were primiparous. There were no differences between the group receiving multiple micronutrients and the group receiving iron-folic acid in mean weight (51.2 and 51.0 kg, respectively) or height 1) . Less than one-tenth of women started supplementation in the first trimester in both groups.
Compliance with daily supplements was high in both groups, with a mean of 136 and 140 supplements consumed in the group receiving multiple micronutrients and the group receiving iron-folic acid, respectively, consumed during pregnancy and in the first 30 days postpartum. The distribution of the total number of tablets consumed is shown in table 2. About 70% of the women in both groups consumed at least 120 supplements. The women in the group receiving multiple micronutrients and the group receiving iron-folic acid consumed the supplements for a mean of 68% and 71% of days of participation, respectively. Few side effects were reported, and there were no significant differences between the groups in the incidence of side effects.
The mean gestational age at birth (table 3) did not differ between groups, at 38.1 weeks for the group receiving multiple micronutrients and 38.0 weeks for the iron-folic acid group (p = .61).* The mean birthweight was 3,094 ± 438 g in the group receiving multiple micronutrients and 3,054 ± 419 g in the iron-folic acid group (p = .21). The prevalence of LBW was 6.3% and 7.3%, respectively (p = .667). Birth length and head circumference also did not differ significantly between the two groups.
The rates of miscarriage, stillbirth, and neonatal death did not differ between the treatment and the control group (table 4) . However, when all three categories are combined, women receiving multiple micronutrient supplements appeared to benefit over the control * Only those with a gestational age at birth between 27 and 45 weeks were included in the analysis of gestational age at birth. group at the borderline of significance, with p = .09 (OR = 0.6; 95% CI, 0.37 to 1.04). Further stratification analysis showed that the number of supplements consumed had a differential impact on fetal loss and neonatal death. Women in the group receiving multiple micronutrients who consumed 90 or more supplements had a significant reduction in the combined risk of fetal loss or neonatal death (OR = 0.45; 95% CI, 0.22 to 0.95) as compared with women in the control group. The impact was not significant among women consuming fewer than 90 supplements (OR = 0.72; 95% CI, 0.32 to 1.59).
Although the rate of anemia was higher in the group receiving multiple micronutrients at baseline, the trend in anemia rates by the third trimester was similar in the two groups ( fig. 2A) . Comparisons of baseline serum levels measured during the last trimester showed that the mean levels of hemoglobin ( fig. 2B ) and zinc ( fig. 3A ) declined significantly in both groups (p < .05); however, serum retinol improved in the group 
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Preventing low birthweight receiving multiple micronutrients (p = .08) but not in the control group ( fig. 3B) . Iodine levels increased in both groups.
Discussion
This efficacy study attempted to assess the impact of supplementation with multiple micronutrients and iron-folic acid on birthweight, pregnancy outcome, and micronutrient status in women. By distributing supplements directly to women in their homes and observing their intake of the supplements, high rates of adherence to supplementation were obtained. Nearly three-quarters of the women in both groups consumed more than 120 supplements during pregnancy and the first 30 days postpartum. On the assumption that they took the maximum of 30 supplements during the postpartum period, these women consumed at least 90 supplements during pregnancy. This finding compares with only 29% of women who consumed at least 90 supplements during pregnancy as reported in the most recent Indonesia Demographic and Health Survey [19] .
In the effectiveness study conducted in parallel with this study, in which supplements were delivered once a month, the mean number of supplements consumed was less, at 107 [20] . The mean adherence (defined as the percentage of days since enrollment on which women could take supplements during which supplements were actually taken) was about 70% in both groups. This means that on average women consumed the supplements on 5 of 7 days. No difference in adherence rates was seen between the two groups. However, even with active recruitment of pregnant women within the community, less than 10% of women started supplementation in the first trimester. Ensuring that women have access to supplements means that they will consume them, but starting supplementation during pregnancy is difficult even in a research study such as this. Reaching women before pregnancy may be necessary in order to improve micronutrient status before the second trimester.
Multivitamin supplementation was associated with a lower prevalence of LBW (6.3% in the group receiving multiple micronutrients vs. 7.3% in the iron-folic acid group). The sample size calculations predicted a 50% reduction in the rate of LBW, from 10% to 5%. The rate of LBW in our population was lower than that found in other Indonesian studies [15, 16] , and the number of infants for whom birthweight data were available (384 in the group receiving multiple micronutrients and 341 in the iron-folic acid group) in this study was smaller than the number needed to account for the additional 20% cluster design effect (342 × 1.2 = 410). Therefore, the calculated sample size was inadequate to detect significant differences. In the absence of a placebo control, this study could not detect whether there was a net benefit of both antenatal supplements in reducing the rate of LBW over no supplementation whatsoever. Whether this difference of 14% or the mean birthweight difference of 40 g is programmatically relevant is controversial [21, 22] .
Among women receiving multiple micronutrient supplements, only serum retinol levels increased significantly between baseline and the third trimester, resulting in a significant difference between the group receiving multiple micronutrients and the control group (p < .01). Although hemoglobin and ferritin levels during the last trimester were higher among women receiving iron-folic acid than among those receiving multiple micronutrient supplements, the iron-folic acid group had significantly higher levels at baseline. Despite the fact that both the intervention and the control supplements contained iron, neither supplement was able to fully compensate for the hemodilution occurring during pregnancy and prevent the decline in iron status between baseline and the last trimester. Surprisingly, zinc status did not improve with the use of multiple micronutrients, but improvement in zinc status may be related to measurement issues.
Although the study was not powered to detect the impact of multiple micronutrient supplementation on fetal loss and neonatal death compared with iron-folic acid, we observed a decrease in the combined outcome of fetal loss or neonatal death among women consuming 90 or more supplements.
Conclusions
This efficacy trial showed that multiple micronutrient supplements and iron-folic acid can be successfully distributed to pregnant women. When distribution is successful and women are supported to take supplements, adherence is not a problem. The slight increase in mean birthweight and the decrease in the rate of LBW, even though not significant, are consistent with the results of other studies reported in this journal supplement. The benefit of multiple micronutrient use on reduction of pregnancy loss is intriguing as well. Even though the amount of iron in the multiple micronutrient supplement was half that in the iron-folic acid supplement, no differences in anemia levels were noted between the two groups, a result suggesting that the inclusion of other nutrients in the multiple micronutrients is beneficial in addressing anemia.
